about
Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells.Electronically Rich N-Substituted Tetrahydroisoquinoline 3-Carboxylic Acid Esters: Concise Synthesis and Conformational StudiesDesigning allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIaPlasmin regulation through allosteric, sulfated, small molecules.Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin.Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.Factor XIa inhibitors: A review of the patent literature.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases.Synthesis of glycosaminoglycan mimetics through sulfation of polyphenols.Glycosaminoglycan-protein interaction studies using fluorescence spectroscopy.Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics.Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor.A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin.Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan MimeticsRecent advances in the discovery and development of factor XI/XIa inhibitorsTargeting factor XI(a) for anticoagulation therapy: a patent landscapeFactor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleedingThe In Vitro Effects of Pentamidine Isethionate on Coagulation and FibrinolysisNew Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations
P50
Q33975255-171B997B-EE74-4D2A-BE53-6DB38A122CBDQ34061158-93678577-FB22-4AF6-8AE2-CD81CFEB3641Q34292151-911EC83D-84FC-4E97-833B-DEEFC0AA674EQ34435690-8A50B17F-596A-436D-918F-AEC5704664BFQ34547334-5A1ABC0E-A999-4D77-9591-9DF68F44F012Q35540006-43E36B7D-5846-49E3-AFAF-8B9F586CD1CCQ35920828-730C1376-6E84-450D-8152-11A553E20712Q35981965-D1FB49AA-97E6-45EA-BF24-83A4A2510C2AQ36088633-78B86E61-018F-43D4-A6B2-53A41738E1DCQ36129629-0886BF6C-0148-42ED-9380-2A624F64540FQ37087491-DF5FBCCC-8138-406A-A50B-B976FB90EECFQ38198582-EC1215DA-9AB1-4CD6-A956-A7C4BC2FC34CQ38265427-368A323A-AB14-4D6C-A2E2-80EA71AA0C00Q45004660-F2DD801D-2CFA-4079-B20A-91B248BFEA69Q45004666-AADFF7A5-6D03-4B91-AB70-A0DF717AFDA6Q45048962-6898F5F3-4B1B-4D55-B39E-6361DEBDE959Q45060094-329C6DAA-9192-46A1-9D16-866EEDB725D1Q49833933-10AD386A-7F56-4901-A89B-5770F1098247Q59354212-198EB056-FCFC-40CB-A7A0-4B3B48BA70ACQ88569228-7C355F91-2CFD-4ECE-9B33-5381FBBF9AA6Q89711393-3209BD1B-789D-4674-9440-30A1507DC556Q92053238-C4DEEE47-C542-4BE6-93CB-9633183A58A8Q92516680-80BC51ED-0D9D-415C-8792-781401D75AF0Q92589948-79425F1D-9B24-4847-8C6A-A74610D8EDE5Q92940962-1CC9F70A-6075-4B18-84F3-2DB07CDFBCF3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rami A Al-Horani
@ast
Rami A Al-Horani
@en
Rami A Al-Horani
@es
Rami A Al-Horani
@nl
Rami A Al-Horani
@sl
type
label
Rami A Al-Horani
@ast
Rami A Al-Horani
@en
Rami A Al-Horani
@es
Rami A Al-Horani
@nl
Rami A Al-Horani
@sl
prefLabel
Rami A Al-Horani
@ast
Rami A Al-Horani
@en
Rami A Al-Horani
@es
Rami A Al-Horani
@nl
Rami A Al-Horani
@sl
P106
P21
P31
P496
0000-0001-9146-2662
P569
2000-01-01T00:00:00Z